Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
79756-69-7
Pomalidomide was approved on February 8
Inhibiting the SAC could represent a promising new approach to selectively target cancer cells
InChi: InChI=1S/C18H17Cl2FN4OS
Doxazosin rasugrel (Maleic acid) 79756-69-7Doxazosin is an 1 adrenergic receptor blocker that inhibits the binding of norepinephrine, which is released from sympathetic nerve terminals, to the 1 receptors on the membrane of vascular smooth muscle cells. Blockages of the alpha 1 adrenergic action on the vascular smooth muscles lead to a decrease in vascular resistance and antihypertensive activity. This agent also shows high affinity to alpha 1c adrenoceptor, the predominant functional type in
US$ 24.00
US$ 17.00
US$ 64.00
US$ 26.00
US$ 16.00
US$ 12.00
US$ 16.00
US$ 34.99
US$ 49.99
US$ 49.99
US$ 49.99
US$ 49.99